Plain-English translation of NCT07111195 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial evaluates ONCOhabitats, an advanced imaging software that analyzes MRI scans to create detailed maps of brain tumors. The goal is to see whether this software can help doctors predict how patients will respond to treatment and make better decisions about surgery and follow-up care for people with glioblastoma, an aggressive type of brain cancer.
Glioblastoma is a serious brain cancer, and doctors need better tools to understand each patient's tumor and predict which treatments will work best. This trial aims to prove that this imaging software can provide valuable information to help personalize treatment plans and improve outcomes.
You likely qualify if…
You likely don't qualify if…
You will have your preoperative MRI scans analyzed using the ONCOhabitats software before your scheduled brain tumor surgery. Your doctors may also collect small tissue samples from different areas of the tumor during surgery to compare with the imaging results. Researchers will then track your treatment response and long-term outcomes to see whether the imaging information helped predict how well you would respond to standard treatments like chemotherapy and immunotherapy.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Spain